# Frequency Electronics Inc: Form 10-Q for the period ended Oct 31, 2018

- Company: [Frequency Electronics Inc](/companies/feim.md) (CIK 39020)
- Form: 10-Q
- Filed: 2018-12-14
- Accepted by EDGAR: Dec 14, 2018, 14:16 ET
- Period: 2018-10-31
- Accession: 0001185185-18-002176
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/39020/000118518518002176/freqelec20181031_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/39020/000118518518002176/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-10-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-08-01 to 2018-10-31 | $12.1m | us-gaap:Revenues |
| Revenue | 6 months, 2018-05-01 to 2018-10-31 | $23.2m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2018-08-01 to 2018-10-31 | $8.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2018-05-01 to 2018-10-31 | $14.9m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2018-08-01 to 2018-10-31 | $4.0m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2018-05-01 to 2018-10-31 | $8.3m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-08-01 to 2018-10-31 | $1.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2018-05-01 to 2018-10-31 | $3.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-08-01 to 2018-10-31 | $2.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2018-05-01 to 2018-10-31 | $5.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-08-01 to 2018-10-31 | −$230.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2018-05-01 to 2018-10-31 | −$146.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2018-08-01 to 2018-10-31 | $17.0k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2018-05-01 to 2018-10-31 | $34.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2018-08-01 to 2018-10-31 | −$30.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2018-05-01 to 2018-10-31 | −$23.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-08-01 to 2018-10-31 | $122.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2018-05-01 to 2018-10-31 | $153.0k | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months, 2018-08-01 to 2018-10-31 | 9,102,039 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2018-05-01 to 2018-10-31 | 9,045,838 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2018-05-01 to 2018-10-31 | −$1.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2018-05-01 to 2018-10-31 | $1.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2018-10-31 | $3.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-10-31 | $51.7m | us-gaap:AssetsCurrent |
| Total assets | at 2018-10-31 | $83.7m | us-gaap:Assets |
| Current liabilities | at 2018-10-31 | $4.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-10-31 | $19.4m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-10-31 | $64.2m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 26,748 characters.

*“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995:*

The statements in this quarterly report on Form 10-Q regarding future earnings and operations and other statements relating to the future constitute “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1933 or the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “will,” “could,” “should,” “would,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “objective,” “seek,” “strive,” “might,” “likely result,” “build,” “grow,” “plan,” “goal,” “expand,” “position,” or similar words, or the negatives of these words, or similar terminology, identify forward-looking statements. All statements by the Company that address activities, events or developments that the Company expects or anticipates will occur in the future, including all statements by the Company regarding its expected financial position, revenues, cash flows and other operating results, business position, legal proceedings or similar matters, are forward-looking statements. These statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties, and a number of factors could cause the Company’s actual results to differ materially from those expressed in the forward-looking statements referred to above. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company’s products in the marketplace, competitive factors, new products and technological changes, product prices and raw material costs, dependence upon third-party vendors, competitive developments, changes in manufacturing and transportation costs, changes in contractual terms, the availability of capital, and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which relate only to events as of the date on which the statements are made and which reflect management’s analysis, judgments, belief, or expectation only as of such date. Any and all of the forward-looking statements contained in this Form 10-Q and any other public statement by the Company or its management may turn out to be incorrect. The Company expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

### Critical Accounting Policies and Estimates

The Company’s significant accounting policies are described in Note 1 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2018, filed on July 30, 2018. The Company believes its most critical accounting policies to be the recognition of revenue and costs on production contracts, income taxes, and the valuation of inventory. Each of these areas requires the Company to make use of reasoned estimates including estimating the cost to complete a contract, the net realizable value of its inventory or the market value of its products. Changes in estimates can have a material impact on the Company’s financial position and results of operations. The Company’s significant accounting policies did not change during the six and three months ended October 31, 2018, except for those impacted by the newly adopted accounting standard below.

#### Revenue Recognition

Revenue is recognized when a performance obligation is satisfied, when the expected goods or services are transferred to the customer, in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. A performance obligation is a distinct product or service that is transferred to the customer’s control based on the contract. The transaction price is allocated to each performance obligation and is recognized as revenue upon satisfaction of that performance obligation. The company derives revenue either as (i) units with specifications and frequencies that can be used by multiple customers (POT) or (ii) units with specific specifications and frequencies that are used by a specific customer or for government end use (POC).

In prior years a significant portion of our business that was not being accounted for as POC was from contracts where the end customer is the U.S. Government. These production-type contracts under which revenue was previously recorded as POT are currently being recognized as POC following adoption of ASU 2014-09 as noted in Note J to the condensed consolidated financial statements in Part I, Item I of this form 10-Q (“Note J”). As a result, the Company will begin recognizing revenue earlier under these contracts.

Revenues under larger, long-term contracts which generally require billings based on achievement of milestones rather than delivery of product, are reported in operating results using the POC method. On fixed-price contracts, which are typical for commercial and U.S. Government satellite programs and other long-term U.S. Government projects, and which require initial design and development of the product, revenue is recognized on the cost-to-cost method. Under this method, revenue is recorded based upon the ratio that incurred costs bear to total estimated contract costs with related cost of sales recorded as the costs are incurred. Each month management reviews estimated contract costs through a process of aggregating actual costs incurred and estimating additional costs to completion based upon the current available information and status of the contract. The effect of any change in the estimated GM Rate for a contract is reflected in revenues in the period in which the change is known. Provisions for the full amount of anticipated losses on contracts are made in the period in which they become determinable.

On production-type orders, revenue is recorded as units are delivered with the related cost of sales recognized on each shipment based upon a percentage of estimated final program costs. Changes in job performance on long-term contracts and production-type orders may result in revisions to costs and income and are recognized in the period in which revisions are determined to be required. Provisions for anticipated losses on customer orders are made in the period in which they become determinable.

For customer orders in the Company’s FEI-Zyfer segment or smaller contracts or orders in the FEI-NY segment, sales of products and services to customers are reported in operating results based upon (i) shipment of the product or (ii) performance of the services pursuant to terms of the customer order. When payment is contingent upon customer acceptance of the installed system, revenue is deferred until such acceptance is received and installation completed.

#### Costs and Expenses

Contract costs include all direct material costs, direct labor costs, manufacturing overhead and other direct costs related to contract performance. Selling, general and administrative costs are expensed as incurred, except as otherwise noted in Note J above in relation to the adoption of ASU 2014-09.

#### Inventory

In accordance with industry practice, inventoried costs contain amounts relating to contracts and programs with long production cycles, a portion of which will not be realized within one year. Inventory write-downs are established for slow-moving or obsolete items and costs incurred on programs for which production-level orders cannot be determined as probable. Such write-downs are based upon management’s experience and expectations for future business. Any changes arising from revised expectations are reflected in cost of sales in the period the revision is made.

#### Marketable Securities

All of the Company’s investments in marketable securities are Level 1 securities which trade on public markets and have current prices that are readily available. In general, investments in fixed income securities are only in the commercial paper of financially sound corporations or the bonds of U.S. Government agencies. Although the value of such investments may fluctuate significantly based on economic factors, the Company’s own financial strength enables it to wait for the securities to either recover their value or to mature such that any interim unrealized gains or losses are deemed to be temporary.

### RESULTS OF OPERATIONS

The table below sets forth for the six and three months ended October 31, 2018 and 2017 the percentage of consolidated revenues represented by certain items in the Company’s condensed consolidated statements of operations or notes to the condensed consolidated financial statements:

| Revenues | Six months Periods ended October 31, 2018 | 2017 | Three months 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| FEI-NY | 79.1% | 73.7% | 80.3% | 70.5% |
| FEI-Zyfer | 22.0 | 36.8 | 20.9 | 38.5 |
| Less intersegment revenues | (1.1) | (10.5) | (1.2) | (9.0) |
|  | 100.0 | 100.0 | 100.0 | 100.0 |
| Cost of revenues | 64.2 | 68.5 | 66.9 | 76.4 |
| Gross margin | 35.8 | 31.5 | 33.1 | 23.6 |
| Selling and administrative expenses | 22.4 | 23.6 | 21.8 | 25.0 |
| Research and development expenses | 14.1 | 15.8 | 13.2 | 18.6 |
| Operating loss | (0.7) | (7.9) | (1.9) | (20.0) |
| Other income (loss), net | 1.2 | 5.3 | 2.7 | (0.1) |
| Benefit for income taxes | (0.1) | (0.5) | (0.2) | (6.3) |
| Income (Loss) from continued operations | 0.6 | (2.1) | 1.0 | (13.8) |
| (Loss) from discontinued operations, net of tax | 0.0 | (1.9) | 0.0 | (2.1) |
| Net income (loss) | 0.6% | (4.0)% | 1.0% | (15.9)% |

### Revenues

| Segment | Six months Periods ended October 31, 2018 | 2017 | Change |  | Three months 2018 | 2017 | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| FEI-NY | $18,322 | $15,740 | $2,582 | 16.4% | $9,745 | $6,579 | $3,166 | 48.1% |
| FEI-Zyfer | 5,103 | 7,865 | (2,762) | (35.1) | 2,542 | 3,593 | (1,051) | (29.3) |
| Intersegment revenues | (272) | (2,245) | 1,973 | (87.9) | (145) | (835) | 690 | (82.6) |
|  | $23,153 | $21,360 | $1,793 | 8.4% | $12,142 | $9,337 | $2,805 | 30.0% |

For the six months ended October 31, 2018, revenues from commercial and U.S. Government satellite programs increased approximately $2.3 million over the same period of the previous fiscal year, and accounted for approximately 49% of consolidated revenues compared to approximately 42% during this same period in fiscal 2018. Revenues on these contracts are recognized primarily under the POC method. Revenues from the satellite market are recorded in the FEI-NY segment. Revenues from non-space U.S. Government/Department of Defense (“DOD”) customers, which are recorded in both the FEI-NY and FEI-Zyfer segments, increased $2.7 million over the same period of fiscal 2018, and accounted for approximately 45% of consolidated revenues compared to approximately 36% during this same period in fiscal 2018. Other commercial and industrial revenues in this fiscal 2019 period accounted for approximately 6% of consolidated revenues compared to 22% in the prior year. Intersegment revenues are eliminated in consolidation.

For the three months ended October 31, 2018 revenues from commercial and U.S. Government satellite programs increased approximately $2.0 million over the same period of fiscal 2018, and accounted for approximately 48% of consolidated revenues compared to approximately 41% during this same period in fiscal 2018. Revenues from non-space U.S. Government/DOD customers, which are recorded in both the FEI-NY and FEI-Zyfer segments, increased $2.5 million over the same period of fiscal 2018, and accounted for approximately 46% of consolidated revenues compared to approximately 34% during this same period in fiscal 2018. Other commercial and industrial revenues for the three months ended October 31, 2018 accounted for approximately 6% of consolidated revenues compared to 26% during this same period in the prior year.

### Gross Margin

|  | Six months Periods ended October 31, 2018 | 2017 | Change |  | Three months 2018 | 2017 | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
|  | $8,293 | $6,724 | $1,569 | 23.3% | $4,019 | $2,203 | $1,816 | 82.4% |
| GM Rate | 35.8% | 31.5% |  |  | 33.1% | 23.6% |  |  |

For the six and three month period ended October 31, 2018 gross margin and GM Rate increased over the same period in fiscal 2018. The increase to both the gross margin and GM Rate was due to increased revenues, lower repair cost and product mix.

### Selling and Administrative Expenses

*Periods ended October 31,*

| Six months 2018 | 2017 | Change |  | Three months 2018 | 2017 | Change |  |
| ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| $5,182 | $5,046 | $136 | 2.7% | $2,642 | $2,335 | $307 | 13.2% |

For the six months ended October 31, 2018 and 2017, selling and administrative (“SG&A”) expenses were approximately 22% and 24%, respectively, of consolidated revenues. For the three months periods ended October 31, 2018 and 2017, SG&A expenses were approximately 22% and 25% respectively, of consolidated revenues. The increase in SG&A expenses during the six and three months ended October 31, 2018, as compared to the six and three months ended October 31, 2017, was due to additional personnel related expenses and professional fees, partially offset by reductions in various other SG&A accounts.

### Research and Development Expense

*Periods ended October 31,*

| Six months 2018 | 2017 | Change |  | Three months 2018 | 2017 | Change |  |
| ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| $3,257 | $3,364 | $(107) | (3.2)% | $1,607 | $1,734 | $(127) | (7.3)% |

Research and development (“R&D”) expenditures represent investments intended to keep the Company’s products at the leading edge of time and frequency technology and enhance future competitiveness. The R&D rate for the six month period ending October 31, 2018 was 14% compared to 16% of sales for the same period of the previous fiscal year. The R&D rate for the three month period ending October 31, 2018 was 13% compared to 19% of sales for the same period of the previous fiscal year. Customer funded R&D development recorded in revenues is expected to add substantially to overall R&D activity in the full current fiscal year compared to fiscal 2018.

### Operating Income (Loss)

*Periods ended October 31,*

| Six months 2018 | 2017 | Change |  | Three months 2018 | 2017 | Change |  |
| ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| $(146) | $(1,686) | $1,540 | (91.3)% | $(230) | $(1,866) | $1,636 | (87.7)% |

The Company had increased revenue, gross margin, and GM Rate in the six and three months ending October 31, 2018 resulting in reduced operating loss as compared to the same periods of the preceding fiscal year.

### Other Income (Expense)

|  | Six months Periods ended October 31, 2018 | 2017 | Change |  | Three months 2018 | 2017 | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | --- |
| Investment income | $189 | $1,167 | $(978) | (83.8)% | $144 | $13 | $131 | NM% |
| Interest expense | (34) | (41) | 7 | (17.1)% | (17) | (21) | 4 | (19.0)% |
| Other income (expense), net | 121 | 3 | 118 | NM% | 195 | - | 195 | NM% |
|  | $276 | $1,129 | $(853) | (75.6)% | $322 | $(8) | $330 | NM% |

Investment income is derived primarily from the Company’s holdings of marketable securities. Earnings on these securities vary based on fluctuating interest rates, dividend payout levels, and the timing of purchases or sales of securities. In the quarter ending July 31, 2017 the Company divested of all its holdings in equities securities in its investment account, which were converted to cash. As a result, the Company recorded gains of approximately $1.0 million during the six months ended October 31, 2017 as compared to negligible gain or loss in the same period of fiscal 2019. The change in other income (expense) was the result of the proceeds of a life insurance policy of a retired key employee.

### Income Tax Provision (Benefit)

*Periods ended October 31,*

| Six months 2018 | 2017 | Change |  | Three months 2018 | 2017 | Change |  |
| ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| $(23) | $(98) | $75 | (76.5)% | $(30) | $(584) | $554 | (94.9)% |
| Effective tax rate on pre-tax book income: |  |  |  |  |  |  |  |
| (17.7)% | 17.6% |  |  | (32.6)% | 31.2% |  |  |

For the six months ended October 31, 2018, the Company recorded an income tax benefit of $(22,600), which included a discrete income tax provision of $36,700. The calculation of the overall income tax provision for the six months ended October 31, 2018 primarily consisted of foreign taxes and a discrete income tax provision related to the accrual of interest for unrecognized tax benefits. For the six months ended October 31, 2017, the Company recorded an income tax benefit of $(98,000).

For the three months ended October 31, 2018, the Company recorded an income tax benefit of $(29,700), which included a discrete income tax provision of $18,400. The calculation of the overall income tax provision for the three months ended October 31, 2018 primarily consisted of foreign taxes and a discrete income tax provision related to the accrual of interest for unrecognized tax benefits. For the three months ended October 31, 2017, the Company recorded an income tax benefit of $(584,000).

The effective tax rate for the six months ended October 31, 2018 was an income tax benefit of (17.7)% compared to an income tax provision of 17.6% in the comparable prior period. The effective rate for the six months ended October 31, 2018 differs from the U.S. statutory rate of 21% primarily due to the mix of domestic and foreign earnings, a discrete income tax provision related to the accrual of interest for unrecognized tax benefits, and domestic losses for which the Company is not recognizing an income tax benefit.

The effective tax rate for the three months ended October 31, 2018 was an income tax benefit of (32.6)% compared to an income tax provision of 31.2% in the comparable prior period. The effective rate for the three months ended October 31, 2018 differs from the U.S. statutory rate of 21% primarily due to the mix of domestic and foreign earnings, a discrete income tax provision related to the accrual of interest for unrecognized tax benefits, and domestic losses for which the Company is not recognizing an income tax benefit.

Based on the weighting of all evidence, both positive and negative, most notably the three-year cumulative loss, we established a full valuation allowance against our U.S. deferred tax assets during the quarter ended April 30, 2018. If these estimates and assumptions change in the future, the Company may be required to adjust its existing valuation allowance resulting in changes to deferred income tax expense. The Company evaluates the likelihood of realizing its deferred tax assets quarterly.

On December 22, 2017, the legislation commonly known as the Tax Cuts and Jobs Act was enacted into law. In response to the TCJA, the SEC staff issued SAB 118, which provides guidance on accounting for the tax effects of TCJA. The purpose of SAB 118 was to address any uncertainty or diversity of view in applying ASC Topic 740, *Income Taxes* in the reporting period in which the TCJA was enacted. SAB 118 addresses situations where the accounting is incomplete for certain income tax effects of the TCJA upon issuance of a company’s financial statements for the reporting period which include the enactment date. SAB 118 allows for a provisional amount to be recorded if it is a reasonable estimate of the impact of the TCJA. Additionally, SAB 118 allows for a measurement period to finalize the impacts of the TCJA, not to extend beyond one year from the date of enactment.

The Company’s accounting for certain elements of the TCJA was incomplete as of the period ended April 30, 2018, and remains incomplete as of October 31, 2018. However, the Company was able to make reasonable estimates of the effects and, therefore, recorded provisional estimates for these items during the periods ended January 31, 2018 and April 30, 2018. There were no changes to the estimates during the six months ended October 31, 2018.

### Discontinued Operations

|  | Six months Periods ended October 31, 2018 | 2017 | Change |  | Three months 2018 | 2017 | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net Loss | $0 | $(408) | $(408) | 100% | $0 | $192 | $192 | 100% |

The above table represents the net loss for the Gillam segment accounted for as discontinued operations as presented in Note B to the condensed consolidated financial statements I Part I, Item 1 of this Form 10-Q. On April 26, 2018, the Company sold Gillam to a European entity, in a stock purchase agreement, for $1.0 million in cash received on April 27, 2018, and a note payable in three years for an additional $1.0 million. The loss recorded due to the sale of Gillam was approximately $359,000. The calculation of the loss was the carrying amount of the investment on FEI-NY’s books less the retained earnings and remaining equity amounts of Gillam reduced by the cash received and the value of the note receivable. As such Gillam’s results have been classified as discontinued operations in the accompanying Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income for fiscal 2018.

LIQUIDITY AND CAPITAL RESOURCES

The Company’s balance sheet continues to reflect a strong working capital position of $47.4 million at October 31, 2018 and $46.8 million at April 30, 2018. Included in working capital at October 31, 2018 and April 30 2018, is $11.3 million and $14.0 million, respectively, of cash, cash equivalents, and short-term investments. The Company’s current ratio at October 31, 2018 was 12.1 to 1.

Cash used in operations for the six months ended October 31, 2018 was $1.1 million compared to $2.8 million provided by operations in the comparable fiscal 2018 period. The decrease in cash flow in the fiscal 2019 period ended October 31, 2018 resulted primarily from an increase in accounts receivables and a decrease in accounts payables offset by a decrease in inventory, compared to the balances as of the end of the previous fiscal 2018 period ended October 31, 2017. For the six month periods ended October 31, 2018 and 2017, the Company incurred approximately $2.2 million and $1.5 million, respectively, of non-cash operating expenses including depreciation and amortization, inventory reserve adjustments, and accruals for employee benefit programs.

Net cash used in investing activities for the six months ended October 31, 2018, was $2.6 million compared to $5.6 million provided by investing activities in the same period of fiscal 2018. During the fiscal 2019 period, marketable securities were sold or redeemed in the amount of $947,000 compared to $6.5 million of such redemptions during the fiscal 2018 period. For the fiscal 2019 period, approximately $2.2 million of marketable securities were purchased. There were no marketable securities purchased for the same period in fiscal 2018. In the six months ended October 31, 2018 and 2017, the Company acquired property, plant and equipment in the amount of approximately $1.3 million and $883,000, respectively. The Company discontinued investing in equity securities in fiscal 2018 as part of its cash management strategy. The Company may continue to invest cash equivalents as dictated by its investment and acquisition strategies.

There was no cash provided by financing activities for the six months ended October 31, 2018 compared to $1,000 provided in the six months ended October 31, 2017.

The Company has been authorized by its Board of Directors to repurchase up to $5 million worth of shares of its common stock for treasury whenever appropriate opportunities arise but it has neither a formal repurchase plan nor commitments to purchase additional shares in the future.

As of October 31, 2018, the Company has repurchased approximately $4 million of its common stock out of the $5 million authorization. For the six months ended October 31, 2018 and 2017, there were no repurchases of shares.

The Company will continue to expend resources to develop, improve and acquire products for space applications, guidance and targeting systems, and communication systems which management believes will result in future growth and profitability. During fiscal 2018, the Company secured partial customer funding for a portion of its R&D efforts. The customer funds received in connection therewith appear in revenues and are not included in R&D expenses. For fiscal 2019, the Company has secured significant additional customer funding for its R&D activities, and will allocate internal funds depending on market conditions and identification of new opportunities as in fiscal year 2018. The Company expects internally generated cash will be adequate to fund these development efforts. The Company may also pursue acquisitions to expand its range of products and may use internally generated cash and external funding in connection with such acquisitions.

As of October 31, 2018, the Company’s consolidated funded backlog was approximately $38 million compared to $30 million at April 30, 2018, the end of fiscal 2018. Approximately 80% of this backlog is expected to be realized in the next twelve months. Included in the backlog at October 31, 2018 was approximately $8.5 million under cost-plus-fee contracts. The Company excludes from backlog any contracts or awards for which it has not received authorization to proceed and associated funding. The Company expects these contracts to become fully funded over time.

The Company believes that its liquidity is adequate to meet its operating and investment needs through at least December 14, 2019 and the foreseeable future.

The Company’s international business is subject to changes in demand or pricing resulting from fluctuations in currency exchange rates in the Chinese Renminbi to U.S. Dollar exchange rate.

### Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements, other than operating leases, that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

## Controls and procedures

As filed, 1,732 characters.

Disclosure Controls and Procedures. The Company’s management, with the participation of the Company’s chief executive officer and chief financial officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on their evaluation, the Company’s chief executive officer and chief financial officer have concluded that, as of October 31, 2018, the Company’s disclosure controls and procedures were effective to ensure that information relating to the Company, including its consolidated subsidiaries, required to be included in its reports that it filed or submitted under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

Changes in Internal Control Over Financial Reporting. There were no changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended October 31, 2018 to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Filed Dec 14, 2018.
Source: SEC EDGAR, the filing index for accession 0001185185-18-002176. Last ingested by Listed: Nov 5, 2026, 18:05 ET. No prices; not investment advice.
